Disease: Shigellosis and enterotoxigenic Escherichia coli (ETEC)
Total results with these characteristics: 69
- Prevalance of Enterotoxigenic Escherichia coli-Associated Diarrhea and Carrier State in the Developing World
Published in The Journal of Health, Population, and Nutrition, this study assesses the importance of enterotoxigenic Escherichia coli (ETEC) as a diarrhoeal agent in developing countries.
Author: Wenneras C, Erling V
- Prevalence of Infection With Waterborne Pathogens: A Seroepidemiologic Study in Children 6-36 Months Old, San Juan Sacatepequez, Guatemala
This study, published in the Journal of Tropical Medicine and Hygiene, evaluated the feasibility of antibody markers as indicators of infections with water-borne pathogens in order to determine the epidemiology of water-borne diarrheal …
Author: Steinberg E, Mendoza C, Glass R, et al.
- Progress and Hurdles in the Development of Vaccines Against Enterotoxigenic Escherichia coli in Humans
This article, published in the Expert Review of Vaccines, describes the status of vaccines under development to address enterotoxigenic Escherichia coli (ETEC), which have been designed to stimulate local intestinal immunity and are delivered either …
Author: Zhang W, Sack DA
- Protecting Aluminum-Adjuvanted Vaccines From Freeze Damage
This fact sheet describes how PATH developed a low-cost and straightforward technology for protecting aluminum-adjuvanted liquid vaccines from the irreversible damage that results from freezing. Many current vaccines of importance to global …
- Protecting Children From Diarrheal Disease: PATH Takes a Comprehensive Approach to Combating This Leading Cause of Child Deaths
This fact sheet provides an overview of PATH's work, including vaccine development and introduction, in protecting children from diarrheal disease.
- PubMed Searches: ETEC and Shigella
These pre-formatted PubMed searches will retrieve journal citations and available abstracts that address relevant issues related to ETEC and Shigella. Documents may be ordered through Loansome Doc if you have established an agreement with a …
- Reaching a Consensus on Management Practices and Vaccine Development Targets for Mitigation of Infectious Diarrhoea Among Deployed US Military Forces
Published in the Journal of Evalution in Clinical Practice, this study was part of a research effort to identify and quantify factors related to the cost-effectiveness of a vaccine acquisition strategy to reduce the burden of infectious diarrhea on …
Author: Riddle MS, Tribble DR
- Reactive Arthritis Following Culture-Confirmed Infections with Bacterial Enteric Pathogens in Minnesota and Oregon: A Population-based Study
This article, published in Annals of the Rheumatic Diseases, describes the epidemiology and clinical spectrum of reactive arthritis (ReA) following culture-confirmed infection with bacterial enteric pathogens in a population-based study in …
Author: Townes JM, Deodhar AA, Laine ES, et al.
- Recent Progress Towards Development of a Shigella Vaccine
The burden of dysentery due to shigellosis among children in the developing world is a major concern, but no licensed vaccine is available. This review article, published in Expert Review of Vaccines, provides an update on Shigella vaccine …
Author: Camacho AI, Irache JM, Gamazo C
- Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines
This article, published in Clinical and Vaccine Immunology, reports on a study which found that a lower dose than used previously of the human challenge model for enterotoxigenic Escherichia coli diarrhea using strain H10407 is sufficient for …
Author: Harro C, Chakraborty S, Feller A, et al.
- A Review of Vaccine Research and Development: Human Enteric Infections
Published in the journal Vaccine, the article reviews the state of the art in vaccine research and development against human viral and bacterial enteric infections of public health importance.
Author: Girard MP, Steele D, Chaignat CL, Kieny MP
- Setting Research Priorities to Reduce Global Mortality From Childhood Diarrhea by 2015
To assist donors in understanding the potential of different research avenues to contribute to reducing the burden of disease and disability, the Child Health and Nutrition Research Initiative (CHNRI) of the Global Forum for Health Research recently …
Author: Fontaine O, Kosek M, Bhatnagar S, et al.
This web page provides information on shigellosis disease burden and vaccine development, as well as relevant links.
Author: World Health Organization
- State of the Art of New Vaccines: Research and Development
This document analyzes research and development activities for vaccines against infectious diseases of public health importance. Disease groups covered include diarrheal disease, sexually transmitted diseases, respiratory infections, bacterial …
Author: World Health Organization
- Summary of Vaccine Stability Data
These documents provide the latest stability data for commonly used vaccines and current research on vaccine formulations and platform technologies. Data are sorted by vaccine in a table format in both documents.
Author: PATH, Working in Tandem Ltd.
- Vaccination Against Enterotoxigenic Escherichia coli, A Cause of Travelers' Diarrhea
This review, published in The Journal of Travel Medicine, focuses on the strategies behind development and potential use of currently available vaccines and vaccine candidates against enterotoxigenic Escherichia coli (ETEC) infection. As …
Author: Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N
- Vaccine Development Global Program
This website provides information about the work of PATH’s Vaccine Development Global Program to improve the health of people, especially infants and children living in low-income countries, by accelerating the development of vaccines …
- Vaccines for the Future
This quarterly e-newsletter provides an update on PATH’s efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against the leading causes of childhood deaths in developing-world populations, pneumonia …
- Vaccines in Fast-Dissolving Tablets: Novel Product Format to Ensure Vaccine Effectiveness, Affordability, and Ease of Use
This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations that are manufactured using a standard lyophilization process. The small tablets are packaged in unit-dose blisters offering an …